LFVAX
Price
$28.98
Change
+$0.33 (+1.15%)
Updated
Jun 2 closing price
Net Assets
94.73M
VSCAX
Price
$33.24
Change
+$1.14 (+3.55%)
Updated
Jun 2 closing price
Net Assets
11.22B
Interact to see
Advertisement

LFVAX vs VSCAX

Header iconLFVAX vs VSCAX Comparison
Open Charts LFVAX vs VSCAXBanner chart's image
LFVAX vs VSCAX Comparison Chart in %
View a ticker or compare two or three
VS
LFVAX vs. VSCAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFVAX is a Hold and VSCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 11.2B vs. LFVAX (94.7M). VSCAX pays higher dividends than LFVAX: VSCAX (0.20) vs LFVAX (0.00). LFVAX was incepted earlier than VSCAX: LFVAX (26 years) vs VSCAX (27 years). LFVAX (1.35) is less costly to investors than VSCAX (1.10). LFVAX is a more actively managed with annual turnover of: 77.00 vs. VSCAX (52.00). LFVAX (6%) and VSCAX (6%) have equivalent initial investment costs. VSCAX has a lower initial minimum investment than LFVAX: VSCAX (1000) vs LFVAX (1500). VSCAX annual gain was more profitable for investors over the last year : 46.28 vs. LFVAX (20.68). VSCAX return over 5 years is better than : 49.52 vs. LFVAX (-9.81).
LFVAXVSCAXLFVAX / VSCAX
Total Expense Ratio1.281.10116%
Annual Report Gross Expense Ratio1.351.10123%
Fund Existence26 years27 years-
Gain YTD11.52226.82743%
Front Load6%6%105%
Min. Initial Investment15001000150%
Min. Initial Investment IRAN/AN/A-
Net Assets94.7M11.2B1%
Annual Yield % from dividends0.000.20-
Returns for 1 year20.6846.2845%
Returns for 3 years21.7384.7726%
Returns for 5 years-9.8149.52-20%
Returns for 10 years-10.65103.62-10%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEREX15.030.25
+1.69%
First Eagle Global Real Assets I
ERHSX13.49N/A
N/A
Eaton Vance Worldwide Health Sci R
JVAIX38.94N/A
N/A
JPMorgan Value Advantage L
PSVIX17.17N/A
N/A
Virtus NFJ Small-Cap Value Inst
PCEKX27.10N/A
N/A
Victory Pioneer Core Equity R6